CHLORTHALIDONE | A086831 | MYLAN PHARMACEUTICALS INC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Clinipace Worldwide FDA-2015-P-3299 · 7 docket documents Clinipace Worldwide filed this petition on behalf of a client requesting that the FDA determine whether THALITONE 15 mg (chlorthalidone tablets, NDA 019574), discontinued by Citron Pharma LLC, was withdrawn for reasons of safety or effectiveness, and if not, that the FDA accept an ANDA for a generic | 505(q) | 2015-09-11 | Granted | Clinipace Worldwide |
Source: Regulations.gov. FDA citizen petitions matched by application number.
Highest NADAC/Unit
$0.1253
per ea
Lowest NADAC/Unit
$0.0882
per ea
Brand NDCs
0
Generic NDCs
5
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 00378021301CHLORTHALIDONE 50 MG TABLET | $0.1253 | EA | Generic | — | 2026-06-17 |
| 00378021310CHLORTHALIDONE 50 MG TABLET | $0.1253 | EA | Generic | — | 2026-06-17 |
| 00378022201CHLORTHALIDONE 25 MG TABLET | $0.0882 | EA | Generic | — | 2026-06-17 |
| 00378022210CHLORTHALIDONE 25 MG TABLET | $0.0882 | EA | Generic | — | 2026-06-17 |
| 51079005820CHLORTHALIDONE 25 MG TABLET | $0.0882 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.